141 related articles for article (PubMed ID: 10499236)
21. Pharmacokinetics and bioequivalence of 2 meloxicam oral dosage formulations in healthy adult horses.
Vivancos M; Barker J; Engbers S; Fischer C; Frederick J; Friedt H; Rybicka JM; Stastny T; Banse H; Cribb AE
Can Vet J; 2015 Jul; 56(7):730-6. PubMed ID: 26130835
[TBL] [Abstract][Full Text] [Related]
22. The steady-state pharmacokinetics and bioequivalence of carprofen administered orally and subcutaneously in dogs.
Clark TP; Chieffo C; Huhn JC; Nimz EL; Wang C; Boy MG
J Vet Pharmacol Ther; 2003 Jun; 26(3):187-92. PubMed ID: 12755902
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
Cheng Z; Welsh E; Nolan A; McKellar QA
Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
[TBL] [Abstract][Full Text] [Related]
24. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses.
Landoni MF; Lees P
J Vet Pharmacol Ther; 1995 Dec; 18(6):446-50. PubMed ID: 8789698
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
Williams RJ; Boudinot FD; Smith JA; Knight AP
Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
Gerring EL; Lees P; Taylor JB
Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
[TBL] [Abstract][Full Text] [Related]
29. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses.
Navarre CB; Ravis WR; Nagilla R; Simpkins A; Duran SH; Pugh DG
J Vet Pharmacol Ther; 2001 Jun; 24(3):227-31. PubMed ID: 11442803
[No Abstract] [Full Text] [Related]
31. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats.
Eltom SE; Guard CL; Schwark WS
J Vet Pharmacol Ther; 1993 Jun; 16(2):141-51. PubMed ID: 8345564
[TBL] [Abstract][Full Text] [Related]
32. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).
Kadir A; Ali BH; al Hadrami G; Bashir AK; Landoni MF; Lees P
J Vet Pharmacol Ther; 1997 Feb; 20(1):54-60. PubMed ID: 9049950
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
[TBL] [Abstract][Full Text] [Related]
34. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Foreman JH; Ruemmler R
Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.
Broome TA; Brown MP; Gronwall RR; Casey MF; Meritt KA
Can J Vet Res; 2003 Oct; 67(4):297-302. PubMed ID: 14620867
[TBL] [Abstract][Full Text] [Related]
36. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
37. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
Holland B; Fogle C; Blikslager AT; Curling A; Barlow BM; Schirmer J; Davis JL
J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
[TBL] [Abstract][Full Text] [Related]
40. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
